European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Jesús Rodríguez‐Baño, Elena Carrara et al.|Clinical Microbiology and Infection|2021Cited by 1k
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, Özlem Kurt Azap et al.|The Lancet Infectious Diseases|2017Cited by 521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, H. R. Cross, Michelle Earley et al.|The Lancet Infectious Diseases|2021Cited by 338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyDavid van Duin, Robert A. Bonomo, César A. Arias et al.|The Lancet Infectious Diseases|2020Cited by 328
Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to actionAdrián Camacho-Ortíz, Massimo Sartelli, Philip S. Barie et al.|World Journal of Emergency Surgery|2023Cited by 81